Terrillion Scott 4
4 · Cara Therapeutics, Inc. · Filed Dec 23, 2022
Insider Transaction Report
Form 4
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
- Sale
Common Stock
2022-12-21$11.27/sh−2,561$28,862→ 99,783 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on December 21, 2021, and does not represent a discretionary trade by the Reporting Person.